CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-22 | TVM Life Science Ventures VI GmbH & Co KG 10% owner | Purchase · Series A Convertible Preferred Stock | +372 | $1,000.00 | $372K | 500 |
| 2017-06-22 | TVM Life Science Ventures VI GmbH & Co KG 10% owner | Purchase · Series A Convertible Preferred Stock | +128 | $1,000.00 | $128K | 500 |
| 2017-06-20 | Kingsley Stuart A Director | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-06-20 | HASTINGS PAUL J Director | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-06-20 | Canute Scott A Director | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-06-20 | BOHLIN GAREN G Director | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-06-20 | Haines Timothy Director | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-06-20 | Freund John Gordon Director | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-06-20 | Birner Hubert Director | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-06-20 | Abingworth LLP 10% owner | Grant or award · Stock Option (Right to Buy) | +6,666 | 6,666 | ||
| 2017-03-10 | Burke Steven Keith SVP and Chief Medical Officer | Exercise or conversion | +12,287 | $2.38 | $29K | 37,601 |
| 2017-03-10 | Burke Steven Keith SVP and Chief Medical Officer | Exercise or conversion | +57,934 | $1.27 | $74K | 95,535 |
| 2017-03-10 | Burke Steven Keith SVP and Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −12,287 | 0 | ||
| 2017-03-10 | Burke Steven Keith SVP and Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −57,934 | 0 | ||
| 2017-01-24 | Toner E. Scott Senior VP of Marketing | Grant or award · Stock Option (Right to Buy) | +73,039 | 73,039 | ||
| 2017-01-24 | NOYES TIMOTHY P President and CEO | Grant or award · Stock Option (Right to Buy) | +122,838 | 122,838 | ||
| 2017-01-24 | Gottlieb Daniel Philip VP Corporate Development | Grant or award · Stock Option (Right to Buy) | +29,215 | 29,215 | ||
| 2017-01-24 | Eldridge, George Arthur Snr VP,CFO,Treasurer,Asst Secy | Grant or award · Stock Option (Right to Buy) | +53,119 | 53,119 | ||
| 2017-01-24 | Burke Steven Keith SVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +53,119 | 53,119 | ||
| 2016-12-02 | Burke Steven Keith SVP and Chief Medical Officer | Gift | −2,500 | 30,314 |
Page 22 of 24 · 473 trades